Doctors say Pope Francis receiving occasional supplemental oxygen, responding to strengthened drug therapy for pneumonia.
A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.
Bristol Myers Squibb (BMS) has shared positive overall survival (OS) results from a late-stage study of its Opdivo (nivolumab ...
Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...